U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C33H50N4O6S
Molecular Weight 630.838
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of REMIKIREN

SMILES

CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3CCCCC3)[C@@H](O)[C@@H](O)C4CC4

InChI

InChIKey=UXIGZRQVLGFTOU-VQXQMPIVSA-N
InChI=1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1

HIDE SMILES / InChI

Molecular Formula C33H50N4O6S
Molecular Weight 630.838
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Remikiren (Ro 42-5892) is a very potent renin inhibitor in vitro and in vivo. Clinical results show that remikiren is a potent orally active renin inhibitor inducing a long lasting blood pressure decrease. Remikiren development has been discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P00797
Gene ID: 5972.0
Gene Symbol: REN
Target Organism: Homo sapiens (Human)
0.7 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors.
2009
Purification and characterization of recombinant human renin for X-ray crystallization studies.
2008-06-26
Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors.
2008-05
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.
2008
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.
2008
Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension.
2007
Functional expression of the renin-angiotensin system in human podocytes.
2006-03
Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
2005-02
Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules.
2004-08
Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma.
2004-03-08
Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer.
2003-02
The power of visual imagery in synthesis planning. Stereocontrolled approaches to CGP-60536B, a potent renin inhibitor.
2002-06-14
Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals.
1996-03
Discovery of remikiren as the first orally active renin inhibitor.
1993-02

Sample Use Guides

Patients with essential hypertension: 600 mg orally for 8 days
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:17:07 GMT 2025
Edited
by admin
on Mon Mar 31 18:17:07 GMT 2025
Record UNII
LC7FBL96A4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1H-Imidazole-5-propanamide, N-[(1S,2R,3S)-1-(cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl]-?-[[(2S)-2-[[(1,1-dimethylethyl)sulfonyl]methyl]-1-oxo-3-phenylpropyl]amino]-, (?S)-
Preferred Name English
REMIKIREN
INN   MART.   WHO-DD  
INN   USAN  
Official Name English
remikiren [INN]
Common Name English
REMIKIREN [MART.]
Common Name English
Remikiren [WHO-DD]
Common Name English
(?S)-N-[(1S,2R,3S)-1-(Cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl]-?-[[(2S)-2-[[(1,1-dimethylethyl)sulfonyl]methyl]-1-oxo-3-phenylpropyl]amino]-1H-imidazole-5-propanamide
Systematic Name English
RO-42-5892
Code English
REMIKIREN [USAN]
Common Name English
RO 42-5892
Code English
Classification Tree Code System Code
NCI_THESAURUS C783
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
WHO-VATC QC09XA01
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
WHO-ATC C09XA01
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
NCI_THESAURUS C270
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
Code System Code Type Description
PUBCHEM
6324659
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
FDA UNII
LC7FBL96A4
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
SMS_ID
100000080825
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
USAN
FF-2
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
DRUG BANK
DB00212
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
EPA CompTox
DTXSID60155121
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
CHEBI
8803
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
INN
6876
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
EVMPD
SUB10273MIG
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
NCI_THESAURUS
C73099
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
WIKIPEDIA
REMIKIREN
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
ChEMBL
CHEMBL31601
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
CAS
126222-34-2
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
DRUG CENTRAL
4696
Created by admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY